-
Je něco špatně v tomto záznamu ?
Changes in cardiovascular autonomic control induced by chronic inhibition of acetylcholinesterase during pyridostigmine or donepezil treatment of spontaneously hypertensive rats
M. Bencze, A. Boroš, M. Behuliak, A. Vavřínová, I. Vaněčková, J. Zicha
Jazyk angličtina Země Nizozemsko
Typ dokumentu časopisecké články
- MeSH
- acetylcholinesterasa MeSH
- cholinesterasové inhibitory farmakologie terapeutické užití MeSH
- deriváty atropinu * MeSH
- donepezil farmakologie MeSH
- hypertenze * farmakoterapie MeSH
- krevní tlak MeSH
- krysa rodu rattus MeSH
- potkani inbrední SHR MeSH
- potkani inbrední WKY MeSH
- pyridostigmin-bromid * farmakologie MeSH
- srdeční frekvence MeSH
- zvířata MeSH
- Check Tag
- krysa rodu rattus MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
Chronic treatment with acetylcholinesterase inhibitors may be a promising therapeutic strategy for treatment of cardiovascular diseases. The aim of our study was to analyze the changes in blood pressure (BP) and heart rate (HR) during 14 days of treatment with two different acetylcholinesterase inhibitors - pyridostigmine (PYR) having only peripheral effects or donepezil (DON) with both peripheral and central effects. In addition, we studied their effects on the cardiovascular response to restraint stress and on sympathovagal control of HR in normotensive Wistar-Kyoto rats (WKY) and spontaneously hypertensive rats (SHR). SHR were characterized by elevated BP and increased low-frequency component of systolic BP variability (LF-SBPV), but their cardiac vagal tone and HR variability (HRV) were reduced compared with WKY. Chronic treatment with either acetylcholinesterase inhibitor decreased HR and increased HRV in both strains. PYR treatment slightly decreased BP and LF-SBPV in the dark phase of the day. Neither drug significantly altered BP response to stress, but PYR attenuated HR increase during restraint stress. Regarding sympathovagal balance, acute methylatropine administration caused a greater increase of HR in WKY than in SHR. Chronic PYR or DON treatment enhanced HRV and HR response to methylatropine (vagal tone) in WKY, whereas PYR but not DON treatment potentiated HRV and vagal tone in SHR. In conclusion, vagal tone was lower in SHR compared with WKY, but was enhanced by chronic PYR treatment in both strains. Thus, chronic peripheral, but not central, acetylcholinesterase inhibition has major effects on HR and its variability in both normotensive and hypertensive rats.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc24013926
- 003
- CZ-PrNML
- 005
- 20240905133352.0
- 007
- ta
- 008
- 240725e20240325ne f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.ejphar.2024.176526 $2 doi
- 035 __
- $a (PubMed)38537804
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Bencze, Michal $u Institute of Physiology, Czech Academy of Sciences, Prague, Czech Republic
- 245 10
- $a Changes in cardiovascular autonomic control induced by chronic inhibition of acetylcholinesterase during pyridostigmine or donepezil treatment of spontaneously hypertensive rats / $c M. Bencze, A. Boroš, M. Behuliak, A. Vavřínová, I. Vaněčková, J. Zicha
- 520 9_
- $a Chronic treatment with acetylcholinesterase inhibitors may be a promising therapeutic strategy for treatment of cardiovascular diseases. The aim of our study was to analyze the changes in blood pressure (BP) and heart rate (HR) during 14 days of treatment with two different acetylcholinesterase inhibitors - pyridostigmine (PYR) having only peripheral effects or donepezil (DON) with both peripheral and central effects. In addition, we studied their effects on the cardiovascular response to restraint stress and on sympathovagal control of HR in normotensive Wistar-Kyoto rats (WKY) and spontaneously hypertensive rats (SHR). SHR were characterized by elevated BP and increased low-frequency component of systolic BP variability (LF-SBPV), but their cardiac vagal tone and HR variability (HRV) were reduced compared with WKY. Chronic treatment with either acetylcholinesterase inhibitor decreased HR and increased HRV in both strains. PYR treatment slightly decreased BP and LF-SBPV in the dark phase of the day. Neither drug significantly altered BP response to stress, but PYR attenuated HR increase during restraint stress. Regarding sympathovagal balance, acute methylatropine administration caused a greater increase of HR in WKY than in SHR. Chronic PYR or DON treatment enhanced HRV and HR response to methylatropine (vagal tone) in WKY, whereas PYR but not DON treatment potentiated HRV and vagal tone in SHR. In conclusion, vagal tone was lower in SHR compared with WKY, but was enhanced by chronic PYR treatment in both strains. Thus, chronic peripheral, but not central, acetylcholinesterase inhibition has major effects on HR and its variability in both normotensive and hypertensive rats.
- 650 _2
- $a krysa rodu Rattus $7 D051381
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a potkani inbrední SHR $7 D011918
- 650 12
- $a pyridostigmin-bromid $x farmakologie $7 D011729
- 650 _2
- $a acetylcholinesterasa $7 D000110
- 650 _2
- $a cholinesterasové inhibitory $x farmakologie $x terapeutické užití $7 D002800
- 650 _2
- $a donepezil $x farmakologie $7 D000077265
- 650 _2
- $a potkani inbrední WKY $7 D011921
- 650 12
- $a hypertenze $x farmakoterapie $7 D006973
- 650 _2
- $a krevní tlak $7 D001794
- 650 _2
- $a srdeční frekvence $7 D006339
- 650 12
- $a deriváty atropinu $7 D001286
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Boroš, Almos $u Institute of Physiology, Czech Academy of Sciences, Prague, Czech Republic
- 700 1_
- $a Behuliak, Michal $u Institute of Physiology, Czech Academy of Sciences, Prague, Czech Republic
- 700 1_
- $a Vavřínová, Anna $u Institute of Physiology, Czech Academy of Sciences, Prague, Czech Republic
- 700 1_
- $a Vaněčková, Ivana $u Institute of Physiology, Czech Academy of Sciences, Prague, Czech Republic
- 700 1_
- $a Zicha, Josef $u Institute of Physiology, Czech Academy of Sciences, Prague, Czech Republic. Electronic address: josef.zicha@fgu.cas.cz
- 773 0_
- $w MED00001641 $t European journal of pharmacology $x 1879-0712 $g Roč. 971 (20240325), s. 176526
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/38537804 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20240725 $b ABA008
- 991 __
- $a 20240905133346 $b ABA008
- 999 __
- $a ok $b bmc $g 2143625 $s 1225792
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2024 $b 971 $c - $d 176526 $e 20240325 $i 1879-0712 $m European journal of pharmacology $n Eur J Pharmacol $x MED00001641
- LZP __
- $a Pubmed-20240725